Acuta Capital Erasca Bets Big on Targeted Cancer Therapies
A niche investment move places acuta capital erasca (eras) at the center of Erasca's ambitious quest in targeted canc...
Benchmarks provide a reference point to gauge portfolio performance and risk. This intro explains how comparing returns against a relevant benchmark clarifies decisions and helps align goals.
22,975 articlesA niche investment move places acuta capital erasca (eras) at the center of Erasca's ambitious quest in targeted canc...
A 25-year-old has amassed a $500k stock portfolio, 13 rental properties, and about $10,000 in monthly gross income wh...
NuScale Power has sparked excitement around small modular reactors, but does the hype translate into real investing u...
The market hasn’t moved this year, leaving many investors uneasy about the next move. This guide explains what that c...
A moment captured on camera offers more than a chuckle—it offers real money lessons. Discover how pausing before a pu...
A rare market moment is unfolding, and history offers a compass. This guide breaks down what it means when the stock ...
A leading home-health provider delivered a 74% rise over 12 months, while a prominent fund expanded its ownership to ...
Two retail giants, two very different paths to trillion-dollar status. This guide breaks down the case for Walmart an...
When big deals fall apart, investors face a new reality. This guide breaks down Netflix after deal collapse, spells o...
Looking for a higher yield consistent dividend or steady dividend growth? This in-depth guide compares VIG and FDVV, ...
Webull (Bull) 2025 earnings offer a window into user growth, revenue mix, and paths to profitability. This guide brea...
Political headlines move markets—and your finances. This guide shows how statements like donald trump publicly blames...